chr7-88075657-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001324418.2(ADAM22):c.355C>T(p.His119Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00264 in 1,613,714 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001324418.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM22 | NM_001324418.2 | c.355C>T | p.His119Tyr | missense_variant | 4/32 | ENST00000413139.2 | NP_001311347.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM22 | ENST00000413139.2 | c.355C>T | p.His119Tyr | missense_variant | 4/32 | 5 | NM_001324418.2 | ENSP00000412085.2 |
Frequencies
GnomAD3 genomes AF: 0.00535 AC: 814AN: 152096Hom.: 11 Cov.: 32
GnomAD3 exomes AF: 0.00554 AC: 1382AN: 249350Hom.: 22 AF XY: 0.00446 AC XY: 604AN XY: 135284
GnomAD4 exome AF: 0.00235 AC: 3438AN: 1461500Hom.: 68 Cov.: 30 AF XY: 0.00220 AC XY: 1602AN XY: 727050
GnomAD4 genome AF: 0.00537 AC: 818AN: 152214Hom.: 11 Cov.: 32 AF XY: 0.00556 AC XY: 414AN XY: 74430
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | ADAM22: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
ADAM22-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 29, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at